MitraClip procedure

Severe forms of mitral valve regurgitation, i.e. leaky mitral valves, are treated using open heart surgery. While this has been regarded as the standard approach to treatment for many years, it poses too high a risk for some patients. In these cases, the MitraClip procedure may provide an alternative treatment approach.

When should the MitraClip procedure be used?

Mitral valve regurgitation, i.e. leakiness of the mitral valve, is a very common type of heart disease. For many years, surgery has been widely established as the standard approach to treating severe forms of this condition, with surgical treatment including a number of options, ranging from mitral valve reconstruction to mitral valve replacement. Some patients may be at too high a risk of surgical complications, due to medical reasons such as severe concomitant disease, having previously undergone heart surgery or having received radiation therapy to the chest.

Normale Mitralklappe, Mitralklappenprolaps, "flail leaflet" und funktionelle Mitralklappenschwäche (v.l.n.r.)

What is the MitraClip procedure?

The MitraClip procedure was developed based on the Alfieri stitch technique - a surgical valve reconstruction procedure, whereby the two edges of the valve leaflets are approximated by use of a suture in the middle of the leaflets.



It is a relatively new procedure, and has been performed at our Heart Center since 2009. Our hospital was among the first 5 German hospitals to start using this new form of treatment.

How does the MitraClip procedure work?

Using a special catheter-based delivery system, the MitraClip is inserted in between the two mitral valve leaflets without having to interfere with the normal pumping action of the heart. This procedure does not require the patient's chest to be opened, nor does it require the use of cardiopulmonary bypass (a heart-lung machine).



Instead, a catheter is inserted via the groin and advanced into the left side of the heart. Echocardiography is used to ensure the correct placement of the clip. This ensures that overall, the need for x-ray exposure is relatively low. As x-ray contrast agents are not usually required, this technique is also unproblematic in patients with severe kidney failure. The use of echocardiography (ultrasound) allows the clip to be positioned in the exact center of the leak.

 
  • Standard access: At the start of the procedure, the device catheter is inserted via the groin and advanced through the blood vessels until it reaches the right atrium.
  • Septal crossing: Once inside the right atrium, the catheter is advanced through the septal wall and into the left atrium. The septal wall is only parted slightly to allow the catheter to pass. This means that the small gap can seal itself naturally after the end of the procedure.
  • MitraClip device introduction: Once inside the left atrium, the introducer device is retracted and the MitraClip is advanced.
  • Positioning: Using ultrasound guidance, i.e. electrocardiography, the MitraClip is positioned inside the left atrium and advanced towards the heart valve.
  • The clip is opened and positioned directly above the area of the mitral valve responsible for the majority of the regurgitation.
  • Grasping: The open clip is pushed through the valve, then retracted grasping the leaflets. Positioning can be checked and readjustments made.
  • Once the clip has been positioned in such a way as to ensure elimination of regurgitation, the clip is closed. Proper positioning is assessed to ensure that blood can flow on both sides of the clip.
  • Deployment: The MitraClip remains attached to the valve leaflets, effectively bridging the valve across its middle. The catheter is then removed, and the clip will remain attached to the mitral valve.
  • Before – After: Comparison of mitral regurgitation before and after the procedure: Heart with mitral regurgitation on the left, heart with MitraClip on the right.

Follow-up treatment

MitraClip in position inside the heart valve

After undergoing a MitraClip procedure, many patients will need to take blood-thinning medication, usually for around three months. No other specific medications will need to be prescribed. In fact, as symptoms improve, patients are often able to reduce the amount of medicine they were taking prior to the procedure.

Our Heart Failure Outpatient Clinic offers a special follow-up treatment program for patients who have had a MitraClip fitted. This allows us to monitor patients in terms of heart and mitral valve function, as well as allowing us to adjust medications as and when appropriate.



Follow-up visits are usually scheduled every three to six months, and include cardiac ultrasound testing, ECGs and blood tests, which are used to assess current heart function. Follow-up visits will also include an in-depth consultation with one of our cardiac specialists. We are of course always available to answer any questions that your general practitioner or local cardiology specialist may have

Treatment results

Comparison of mitral regurgitation before and after the MitraClip procedure

Having successfully performed a total of 150 procedures, we have become one of the leading specialist centers in Germany offering this new treatment approach. Nearly all of our patients were able to be treated successfully with the MitraClip procedure, without the need for any additional surgical procedures involving the heart. The close cooperation that exists between our Interventional Cardiology and Cardiac Surgery Departments means that we are able to respond without delay should complications arise, and result in a patient requiring emergency cardiac surgery.


Specialist article

Butter C., PD (Co-Autor), Mitraclip therapy in patients with end-stage systolic heart failure, Eur J Heart failure 2011;13;569-76

 
 
 
 
Relevant information

Emergency numbers

  • Emergencies only:
    112
    Our Emergency Department:
    +49 3338-69 45 21

Contact person

  • Univ.-Prof. Dr. med.
    Christian Butter
    Head of the Department of Cardiology, Immanuel Hospital Bernau Brandenburg Heart Center

    PA to Head of Department Christine Meinecke
    Immanuel Hospital Bernau Brandenburg Heart Center
    Ladeburger Str. 17
    16321 Bernau bei Berlin
    T +49 3338 694-610
    F +49 3338 694-644
    send email
    download vcard

Direct links

 
 

TOn this website, we use cookies, analysis tools to anonymise the access to our website, and plugins to offer social media features. By visiting our site you give us your consent for this use. For more information and tips on how to prevent cookies, please see our Privacy Policy

OK